Silent Voice Survey A survey of prostate cancer patients in Europe OVERVIEW OF RESULTS.

Slides:



Advertisements
Similar presentations
Implementing NICE guidance
Advertisements

What if the patient wants answers... (and you don’t have them) Dr Geraldine Swift and Dr Sonia Mangwana.
Definitions Patient Experience Patient experience at NUH results from a range of activities that all impact upon patient care, access, safety and outcomes.
Survey among men who have had Prostate Cancer Media Briefing: 30 th September 2011.
Patients’ supportive care needs beyond the end of treatment: A prospective, longitudinal study.
GPAQ Survey Results & Summary Analysis for: Marple Cottage Surgery Individual Questions Analysis and Year On Year Comparison (2007/2008 – 2008/2009)
The current management of vasomotor symptoms in breast cancer patients in the UK: Clinician versus Patient perspective. Mei-Lin Ah-See 1,Charlotte Coles.
Prostate Cancer Support Federation Charity Nº: We have no national screening programme for the most common cancer in men and the only test we.
Teen Health Perspective Results “Honestly, most issues are mental like anxiety, stress, worry, and over thinking. They do all not need to be treated with.
Powered by Patient Survey March Powered by 194 Total Responses.
BECOMING PART OF THE PCCNC Our Vision: By working together the citizens of North Carolina will see a day when prostate cancer is no longer a threat to.
- PROSTATE CANCER - Understanding Your Diagnosis Someone to talk to… who understands.
Dove Springs Resident Health Survey Results 2007.
Information Therapy:a must, not just a nice to have 2 June
By Rachel, Xiao Xia, Helen. Introduction Definition Symptoms Causes Prevention Treatment Prognosis Statistics Conclusion.
Resilience and Hope: Kiwi Stories of Breast Cancer Dr. Chris Walsh, Deputy Chair Breast Cancer Aotearoa Coalition New Zealand.
MICHAEL J. CALLAHAN, M.D. GYNECOLOGIC ONCOLOGIST ST. VINCENT CANCER CARE ST. VINCENT INDIANAPOLIS CARING FOR THE WHOLE PATIENT.
Page. 1 Asian Menopause Survey March 2007 Hans Rekers VP Medical Affairs NV Organon.
- Being hospitalized can be a very intimidating experience. - Patients find themselves thrown into a foreign environment and often feel that they.
Documentation Waleed Al-Shehri,BSc.PT King Saud university College of applied Medical Science Rehabilitation Science Department Physical Therapy.
Interdisciplinary Care and Treatment Involves Us TOO James Kiefert, EdD Chairman, Board of Directors Us TOO International Prostate Cancer Education and.
LESSON 7.9: THE PLAN (SOAP) Module 7: Violence Obj. 7.9: Develop a plan to attain health goals for a patient that addresses strengths, needs, and risks.
Priory Fields Patient Participation Group Survey December 2011.
Throckley Primary Care Results of Patient Information Survey
A Summary Of Key Findings From A National Survey Of Voters. #07160.
MUNROS is funded by the European Commission FP7 programme Leads: Christine Bond and Bob Elliott University of.
Survivorship Update January 2015 The Royal Wolverhampton NHS Trust James Owen Senior Cancer Services Manager.
1 Final Version© Ipsos MORI Final Version Evaluation of Adult Cancer Aftercare Services Quantitative and Qualitative Service Evaluation for NHS Improvement.
Therapeutic Education: Cancer Patients on chemotherapy: Shamim Akhter QURESHI MBBS,MPH, Ingénieur d’étude(EHESP) 2 nd June 2012 June 2010.
Slide #1 What is your clinical/academic training or background? Please select ONE answer that best describes your current primary position 1. Medical doctor.
“We are a compassionate team of healthcare professionals providing excellent personal care to Central Minnesota.”
Effective and Supportive Transitions of Care: The Care Teams Role in Reducing Admissions Jim Kinsey, Planetree Presented to Texas Center for Quality and.
Session Fertility and Pregnancy FL-BBM Specific questions Risk of premature ovarian failure Ability to become pregnant Safety of pregnancy.
M EDICAL R ESEARCH F ATIMA A.H AKEEM A L B ASTAKI M RS. T IMM 12 – D M ARCH 10, 2013.
PSA Shared Care Jim Wood. Background A significant number of men with prostate cancer (CaP) are receiving regular hospital follow up (out- patient visits),
End of Life Decisions by Adults with Cancer : Role of Religious Practices and Spiritual Beliefs Rudolph M. Navari, M.D., Ph.D. Assistant Dean and Director.
Internet educated patients, the patient-physician relationship, and cancer screening Yuliya Shneyderman.
EUROPA UOMO European Prostate Passport Recommendations from Berlin
Our Plans for 2015/16 We want to make sure that people in our area are able to live long and healthy lives, both now and in the future, and our plans set.
Ana-Maria Toma (Gabor), Estera Gabor 6th year – Faculty of Medicine
MARIE CURIE ‘SUPPORTING PEOPLE TO DIE AT HOME’ Dee Sissons. Director of Nursing.
Prostate Cancer Coalition of NC A statewide collaborative effort by concerned organizations and individuals to support awareness, early detection, and.
Physical Activity in North Wales Julie A Jones Macmillan Services Effectiveness Lead June 2015.
Breast Cancer in Ghana How are we going to ‘beat’ it? Prof J-N Clegg-Lamptey SAMF Launch.
MBCG Project Primary Results MEDICALSURVEYS-17 RESEARCH GROUP IN COLLABORATION WITH THE EASO.
Essence of Care – Moving Forward Maureen Morgan Department of Health 11 th June 2008 – London.
Patient Participation Survey Results. In general what is the quality of your health?
Prostate Cancer. What is the Prostate Gland What is the prostate Gland Size of a chestnut Just beneath the bladder Urethra runs through its middle Its.
Priory Fields Patient Participation Group Survey December 2011.
Gypsy Case Study Diana J. Wilkie, PhD, RN, FAAN. Slide 2 Comfort: Pain Management Case Studies: Gypsy TNEEL-NE Case Study: Gypsy When the science and.
1 Midterm Issues. 2 Social Context Social context is a specific role that a person has in society –E.g. Doctor, lawyer, patient, voter –Not an issue of.
Decisions, Decisions A second opinion should be your first thought.
SENIOR AUSTRALIANS AND PRESCRIPTION MEDICINES Australian Association of Gerontology NSW 30 August 2013.
k Survey 27 th June Key findings Fractures For 70%, osteoporosis was not discussed by their health professional after.
DEPARTMENT OF RADIOLOGIC TECHNOLOGY AND MEDICAL IMAGING RAD 2325/RT 325 RADIOGRAPHIC PROCEDURES III Inter Hospital Collaborative Research in the Fall 2012.
Aiym Kaiyrlykyzy 1, MD, Sharon Welburn 1, BS, Igor Linkov 2, PhD, Kyle Freese 3, MPH, Dana Bovbjerg 4, PhD, Faina Linkov 3, MPH, PhD University of Pittsburgh,
JHH Prostate Cancer Prostate Cancer Cases Diagnosed 1999 – 2004 Analytic vs. Non-Analytic n=7776 * Analytic - Initially Diagnosed and/or received.
Council of Governors Meeting Tim Bennett – Director of Finance and Steven Vaughan – Director of Operations &Performance July 2011.
THE MEDICAL CENTRE Your Patient Survey Results January 2014.
Support for the Financial and Other Costs of Cancer Care Trish Goldsmith.
Within the Cancer Program in MUH doing the best research and providing the best care to our patients. This is the best cancer care hospital.cancer care.
HOW TO USE THE PRESENTATION THAT FOLLOWS (PLEASE DELETE THIS SLIDE!…)
Understanding Your Role
Informational Needs During Active Surveillance for Prostate Cancer:
Sylvia Lempit, MSN , APRN Yale New Haven Transplantation Center
Caring Your Vision - Special Aspects
Update of breast cancer
What Would You Do in This Case of MDD?
© 2017 Relevate Health Group. All Rights Reserved.
Patient Questionnaire
Presentation transcript:

Silent Voice Survey A survey of prostate cancer patients in Europe OVERVIEW OF RESULTS

Patient demographics

GfK HealthCare 3 Number of patients and age Total Country FranceGermanyItalySpainPoland Total number of patients Age of patientsTotal Country FranceGermanyItalySpainPoland years0%2%0% years6%8%12%4% years30%34%32%38%22%25% Over 65 years63%54%56%58%74%71% Not stated0%2%0%

GfK HealthCare 4 Healthcare professional most involved in patient treatment and management following diagnosis Total Country Healthcare professionalFranceGermanyItalySpainPoland The Urologist67%86%66%72%40%73% The Oncologist23%8%20%14%48%25% Your GP/Primary Care Physician 4%2%4%8%2% The Radiologist2% 4%0%4%0% The Radiotherapist2%0%2%6%0% None of the above1%0%4%0% Don't know2% 0% 6%0%

GfK HealthCare 5 Treatment course undertaken following diagnosis Total Country Treatment course(s)FranceGermanyItalySpainPoland Surgery47%58%60%44%24%50% Hormone therapy39%26%30%70%30%40% Radiotherapy 37%28%40%36%52%29% Chemotherapy9%6%18%2%18%0% Pharmacological treatment / tablets6%2%4%0%8%13% Monitoring phase / waiting for a treatment decision 1%4%0% 2% Infusions (unspec)1%0%2%0% 2% Injections (unspec)0% 2%0% Don't know1%0%2%0%2%0%

How are prostate cancer patients accessing information about their condition?

GfK HealthCare 7 Did patients receive information about prostate cancer at diagnosis? Base: All respondents (Total=252/France=50/Germany=50/Italy=50/Spain=50/Poland=52) JUNE 2009MAIN SURVEY Q: When you were first diagnosed with prostate cancer were you given any information concerning this condition?

GfK HealthCare 8 How informative was the information patients were given about prostate cancer? Base: All who were given any information concerning prostate cancer when first diagnosed (Total=201/France=33/Germany=34/Italy=43/Spain=45/Poland=46) JUNE 2009MAIN SURVEY Q: On a scale of 1 to 4, please rate the information you were given, upon being initially diagnosed with prostate cancer, for each of the following aspects? - Explanation of your condition

GfK HealthCare 9 How informative was the information patients were given about the likely outcome of their diagnosis? Base: All who were given any information concerning prostate cancer when first diagnosed (Total=201/France=33/Germany=34/Italy=43/Spain=45/Poland=46) JUNE 2009MAIN SURVEY Q: On a scale of 1 to 4, where 1 is 'Not at all informative' and 4 is 'very informative', please rate the information you were given, upon being initially diagnosed with prostate cancer, for each of the following aspects?- Explanation of the likely outcome

GfK HealthCare 10 How informative was the information patients were given about their treatment options? Base: All who were given any information concerning prostate cancer when first diagnosed (Total=201/France=33/Germany=34/Italy=43/Spain=45/Poland=46) JUNE 2009MAIN SURVEY Q: On a scale of 1 to 4, where 1 is 'Not at all informative' and 4 is 'very informative', please rate the information you were given, upon being initially diagnosed with prostate cancer, for each of the following aspects? - Explanation of your treatment options

GfK HealthCare 11 Which information sources did patients find most useful following diagnosis? Base: All respondents (Total=252/France=50/Germany=50/Italy=50/Spain=50/Poland=52) JUNE 2009MAIN SURVEY Q:Following your initial diagnosis of prostate cancer, which ONE of the following sources of information did you find most useful?

What is important to prostate cancer patients when making decisions about their treatment options?

GfK HealthCare 13 How do patients prefer treatment decisions to be made? Base: All respondents (Total=252/France=50/Germany=50/Italy=50/Spain=50/Poland=52) JUNE 2009MAIN SURVEY Q:Which ONE of the following options best describes how you would prefer your doctor to approach treatment decisions with you?

GfK HealthCare 14 How informed do patients feel about their treatment options? Base: All respondents (Total=252/France=50/Germany=50/Italy=50/Spain=50/Poland=52) JUNE 2009MAIN SURVEY Q: With regard to the treatment options you were given, which one of the following options best describes how informed you felt?

GfK HealthCare 15 What other factors are important to patients when making treatment decisions? Base: All respondents (Total=252/France=50/Germany=50/Italy=50/Spain=50/Poland=52) JUNE 2009MAIN SURVEY Importance ranking 1st - 4thSide-effects Impact on your lifestyle Impact on your partner / family Cost of the treatment Ranked first42%40%14%4% Ranked second32%35%28%6% Ranked third25%19%45%11% Ranked forth1%6%13%80% Mean Standard deviation Standard error Q: Aside from the effectiveness of your treatment, please rank, in order of their importance to you, the following factors that you feel your doctor should take into account when making treatment decisions.

GfK HealthCare 16 If impact on lifestyle is important to patients, have they discussed this with their physician? Base: All respondents who ranked 'impact on your lifestyle' as the most important factor in their treatment decision (Total=102/France=8/Germany=30/Italy=28/Spain=16/Poland=20) JUNE 2009MAIN SURVEY Q: Having ranked 'impact on lifestyle' as the most important consideration your physician should take into account (aside from the effectiveness of the treatment), have you discussed this with him/her?

GfK HealthCare 17 Why haven’t some patients discussed impact on lifestyle with their physician? Base: All respondents who ranked 'impact on your lifestyle' as the most important factor in their treatment decision but did not discuss this with their physician (Total=31/France=2/Germany=12/Italy=3/Spain=5/Poland=9) JUNE 2009MAIN SURVEY Q: What has held you back from discussing the potential impact your treatment may have on your lifestyle?

GfK HealthCare 18 What is most important to prostate cancer patients following diagnosis? Base: All respondents (Total=252/France=50/Germany=50/Italy=50/Spain=50/Poland=52) JUNE 2009MAIN SURVEY Importance ranking 1st - 4th Controlling my disease Maintaining as much of a normal lifestyle as possible Minimising the impact of my disease on my family Having as few visits to the doctor for treatment as possible Ranked first65%27%6%2% Ranked second24%53%19%4% Ranked third9%17%59%15% Ranked forth2%3%15%80% Mean Standard deviation Standard error Q: Having been diagnosed with prostate cancer, please rank, in order of their importance to you, the following four options.